That overwhelming sleepiness dragging you down might not just be from staying up too late scrolling through TikTok. While everyone occasionally battles the afternoon slump, people with hypersomnia or ...
If you're often exhausted and don't have enough energy to make it through the day, you might ask yourself: Am I sleep-deprived, or am I dealing with a more serious medical condition? Multiple sleep ...
When Katelynn O’Connell takes her lunch break at work, she follows a routine that sets her apart from other employees. Each day at noon, she unfolds a cot in her small office, turns on a white noise ...
There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Alkermes and Takeda ...
One cheerleader is rewriting what determination looks like by pushing boundaries on the mat while managing a chronic sleep disorder Tereza Shkurtaj is a writer-reporter at PEOPLE. She has been working ...
Risk for cardiovascular disease was significantly increased in patients with narcolepsy, highlighting the importance of routine screening in this population. Patients with narcolepsy have a ...
Takeda and Alkermes both took data from their orexin receptor 2 (OX2R)-selective agonists to Singapore this morning as the race to get a new class of narcolepsy drugs approved heats up. Takeda ...
Takeda is on track to submit its much-hyped narcolepsy drug to regulators this fiscal year after the orexin receptor 2 (OX2R)-selective agonist scored a pair of phase 3 wins. The Japanese pharma had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback